Cellebrite DI Ltd. CLBTW
5.25 USD -0.69 (-11.64%)
At closeSep 16, 2024, 4:00 PM EDT
4.50 Day range 5.90
4.50 52-week range 5.90
Financial health
Altman Z-Score
2.71 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 58.2×
FY 2019 5y median 6.8× FY 2025
P/S 9.5×
FY 2019 5y median 5.1× FY 2025
P/B 9.3×
FY 2019 5y median 10.8× FY 2025
P/FCF 28.9×
FY 2019 5y median 38.0× FY 2025
EV/EBITDA 42.7×
FY 2019 5y median 5.6× FY 2025
EV/Sales 9.3×
FY 2019 5y median 4.5× FY 2025
FCF Yield 3.5%
FY 2019 5y median 2.6% FY 2025
Profitability
Gross Margin 84.2%
FY 2019 5y median 83.6% FY 2025
Operating Margin 14.0%
FY 2019 5y median 10.2% FY 2025
Net Margin 16.5%
FY 2019 5y median 16.5% FY 2025
ROE 16.2%
FY 2019 5y median -84.2% FY 2025
ROIC 10.0%
FY 2019 5y median 10.0% FY 2025
ROA 8.3%
FY 2019 5y median 8.3% FY 2025
Growth (YoY)
Revenue 18.6%
FY 2019 FY 2025
Operating Income 16.8%
FY 2019 FY 2025
EPS (diluted) 123.0%
FY 2019 FY 2025
Free Cash Flow 28.1%
FY 2019 FY 2025
Financial Health
Current Ratio 1.6×
FY 2019 5y median 1.6× FY 2025
Quick Ratio 1.5×
FY 2019 5y median 1.5× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA -1.0×
FY 2019 5y median -0.6× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
